(Total Views: 762)
Posted On: 10/17/2020 12:58:28 PM
Post# of 154120
This is insane, they will be evaluating Cenicriviroc (CVC) a small-molecule antagonist for CCR5. This is very likely inferior to Leronlimab and is being tested for HIV and NASH similarly to us.
Read More: https://investorshangout.com/post/view?id=593...z6b9ENtom5
_________________________
To the contrary, this is a very smart and long-expected move to grab the mountains of Big Bucks and bury LL for good. By hook or by crook they will pull a passing p-values for one or even all three of their mabs, secure raving publications in main medical journals (RIP to Dr. Patterson's piece) and mainstream press and make them household names for health professionals in this country.
Read More: https://investorshangout.com/post/view?id=593...z6b9ENtom5
_________________________
To the contrary, this is a very smart and long-expected move to grab the mountains of Big Bucks and bury LL for good. By hook or by crook they will pull a passing p-values for one or even all three of their mabs, secure raving publications in main medical journals (RIP to Dr. Patterson's piece) and mainstream press and make them household names for health professionals in this country.
(1)
(5)
Whatever happens, we have got
Le-Ron-Li-Mab, and they have not.
Le-Ron-Li-Mab, and they have not.
